Add to ORKGand 3.98 for children>59 months. By study year, IRs were 21.25 in 2008, 19.89 in 2009 and 9.80 in 2010. The reduction found in 2010 was significant and due to significant reductions in IRs of IPDs caused by serotypes Picazo et al. BMC Infectious Diseases 2013, 13:50
Despite advances in preventative interventions, invasive pneumococcal disease and pneumonia cause si...
<p>VT-PCV7: IPD caused by PCV7 serotypes; VT-PCV13: IPD caused by 6 additional serotypes in PCV13; N...
Streptococcus pneumoniae serotype 1 (ST1) was an important cause of invasive pneumococcal disease (I...
Background: Characterisation of risk groups who may benefit from pneumococcal vaccination is essenti...
Background: Characterisation of risk groups who may benefit from pneumococcal vaccination is essenti...
OBJECTIVE: The purpose of this study was to monitor the clinical and microbiologic features of invas...
Approximately 800,000 children die each year due to pneumococcal disease and >90% of these deaths oc...
To access publisher's full text version of this article, please click on the hyperlink in Additional...
Abstract We previously conducted nationwide surveil-lance of Streptococcus pneumoniae in 2000–2001 (...
Objectives: The purpose of this study was to compare the incidence rate of invasive pneumococcal dis...
We assessed known risk factors, clinical presentation, and outcome of invasive pneumococcal disease ...
Journal Article; Research Support, Non-U.S. Gov't;Pediatric parapneumonic empyema (PPE) has been inc...
Objective: To estimate the incidence of invasive pneumococcal disease and pneumonia, distribution of...
BackgroundVaccine-serotype (VT) invasive pneumococcal disease (IPD) rates declined substantially fol...
Streptococcus pneumoniae serotype 1 (ST1) was an important cause of invasive pneumococ-cal disease (...
Despite advances in preventative interventions, invasive pneumococcal disease and pneumonia cause si...
<p>VT-PCV7: IPD caused by PCV7 serotypes; VT-PCV13: IPD caused by 6 additional serotypes in PCV13; N...
Streptococcus pneumoniae serotype 1 (ST1) was an important cause of invasive pneumococcal disease (I...
Background: Characterisation of risk groups who may benefit from pneumococcal vaccination is essenti...
Background: Characterisation of risk groups who may benefit from pneumococcal vaccination is essenti...
OBJECTIVE: The purpose of this study was to monitor the clinical and microbiologic features of invas...
Approximately 800,000 children die each year due to pneumococcal disease and >90% of these deaths oc...
To access publisher's full text version of this article, please click on the hyperlink in Additional...
Abstract We previously conducted nationwide surveil-lance of Streptococcus pneumoniae in 2000–2001 (...
Objectives: The purpose of this study was to compare the incidence rate of invasive pneumococcal dis...
We assessed known risk factors, clinical presentation, and outcome of invasive pneumococcal disease ...
Journal Article; Research Support, Non-U.S. Gov't;Pediatric parapneumonic empyema (PPE) has been inc...
Objective: To estimate the incidence of invasive pneumococcal disease and pneumonia, distribution of...
BackgroundVaccine-serotype (VT) invasive pneumococcal disease (IPD) rates declined substantially fol...
Streptococcus pneumoniae serotype 1 (ST1) was an important cause of invasive pneumococ-cal disease (...
Despite advances in preventative interventions, invasive pneumococcal disease and pneumonia cause si...
<p>VT-PCV7: IPD caused by PCV7 serotypes; VT-PCV13: IPD caused by 6 additional serotypes in PCV13; N...
Streptococcus pneumoniae serotype 1 (ST1) was an important cause of invasive pneumococcal disease (I...